Inventiva (IVA) Asset Writedowns and Impairment (2022 - 2024)
Inventiva (IVA) recorded quarterly Asset Writedowns and Impairment of -$9692.0 in Q2 2024, little changed quarter-over-quarter from -$9683.5 in Q4 2023, and up 73.03% on a YoY basis from -$5601.4 in Q3 2023.
Inventiva (IVA) Asset Writedowns and Impairment (2022 - 2024) Analysis & Trends
Inventiva's Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at -$9692.0 for Q2 2024.
- In Q2 2024, Asset Writedowns and Impairment rose 73.03% year-over-year to -$9692.0; the TTM figure through Jun 2024 stood at -$9692.0 (up 73.03% YoY), while the FY2023 annual figure was -$9683.5, up 71.24% from the prior year.
- Asset Writedowns and Impairment was -$9692.0 for Q2 2024 at Inventiva, roughly flat from -$9683.5 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of -$9683.5 in Q4 2023 to a low of -$35934.5 in Q2 2023.
- Historically, Asset Writedowns and Impairment has averaged -$22244.5 across 3 years, with a median of -$21680.1 in 2022.
- The sharpest annual moves came in 2023 and 2024: Asset Writedowns and Impairment jumped 71.24% in 2023, then surged 73.03% in 2024.
- A 3-year view of Asset Writedowns and Impairment shows it stood at -$33668.2 in 2022, then soared by 71.24% to -$9683.5 in 2023, then retreated by 0.09% to -$9692.0 in 2024.
- The last three Asset Writedowns and Impairment figures came in at -$9692.0 (Q2 2024), -$9683.5 (Q4 2023), and -$35934.5 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Inventiva | 8.52 Mn | -260.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -9,691.99 |
| Jun 30, 2024 | -9,691.99 |
| Dec 31, 2023 | -9,683.46 |
| Dec 31, 2023 | -9,683.46 |
| Jun 30, 2023 | -35,934.50 |
| Jun 30, 2023 | -35,934.50 |
| Dec 31, 2022 | -33,668.16 |
| Dec 31, 2022 | -33,668.16 |